Biotech & life sciences recruitment

ICP map

Who we target for biotech clients.

Signals we track

What fires the engine for biotech.

• FDA milestone announcements (IND filings, Phase 2/3 entries, BLA submissions)
• Clinical trial registrations on ClinicalTrials.gov
• Funding rounds from biotech-focused VCs (ARCH, Flagship, Third Rock, Atlas)
• Executive departures from comparable-stage companies
• Manufacturing site expansions or new facility leases

Sample sequence opener

A real first touch for biotech.

This is what a niche-aware, signal-tied opener actually looks like.

[First name] — saw [Company] disclosed Phase 2 readouts for [program] in the latest 10-Q. Congrats on the data. In our work with Series B/C biotech, that milestone reliably triggers a clinical-ops scale-up 3–4 months out — Directors of Clinical Operations, Trial Managers, plus a CRA bench. We track that pattern across the sector and can have a shortlist for [therapeutic area] in front of you inside two weeks. Worth 20 minutes to walk through the candidate map?

Disqualifications

When we say no for biotech.

We'd rather decline upfront than waste your retainer on a niche where our signal layer can't see opportunities.

• ✗Pre-clinical-only with under 50 FTEs — signal layer can't see them
• ✗Generic "biotech" agencies serving any therapeutic area — niche is too broad to filter
• ✗Companies primarily hiring through retained executive search firms